Forbes Earnings Preview: ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. (ACAD) is expected to book a narrower loss than a year ago when it reports first quarter earnings on Tuesday, May 7, 2013 with analysts expecting a loss of 8 cents per share, up from a loss of 12 cents per share a year ago.